Sagittarius Life Science Corp. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 120.757 million compared to TWD 110.258 million a year ago. Operating loss was TWD 24.899 million compared to TWD 23.303 million a year ago. Net loss was TWD 20.378 million compared to net income of TWD 3.129 million a year ago. Basic loss per share was TWD 0.62 compared to basic earnings per share of TWD 0.09 a year ago. For the half year, sales was TWD 216.609 million compared to TWD 218.129 million a year ago. Operating loss was TWD 50.913 million compared to TWD 51.749 million a year ago. Net loss was TWD 47.188 million compared to TWD 31.959 million a year ago. Basic loss per share was TWD 1.44 compared to TWD 0.98 a year ago.